1. Gullo L. Chronic nonpathological hyperamylasemia of pancreatic origin. Gastroenterology 1996; 110: 1905-1908.
2. Gullo L. Familial pancreatic hyperenzymemia.Pancreas 2000; 20: 158-160.
3. Gullo L, Cavicchi L, Tomassetti P,Spagnolo C, Freyrie A, D'Addato M. Effects of ischemia on the human pancreas. Gastroenterology 1996; 111: 1033-1038.
4. Berk JE, Kizu H, Wilding P, Searcy RL. Macroamylasemia: a newly recognized cause for elevated serum amylase activity. N Engl J Med 1967; 277: 941-946.
5. Warshaw AL, Lee KH. Macroamylasemia and other chronic nonspecific hyperamylasemias:
chemical oddities or clinical entities? Am J Surg 1978; 135: 488-493.
6. Levitt MD, Ellis CJ, Meier PB. Extrapancreatic origin of chronic unexplained hyperamylasemia.
N Engl J Med 1980; 302: 670-671.
7. Warshaw AL, Hawboldt MM. Puzzling persistent hyperamylasemia, probably neither pancreatic nor pathologic. Am J Surg 1988; 155: 453-456.
8. Cuckow PM, Foo AY, Jamal A, Stringer MD. Familial hyperamylasaemia. Gut 1997; 40: 689-690.
9. Koda YKL, Vidolin E. Familial hyperamylasemia. Rev Hosp Clin Med S Paulo 2002; 57: 77-82.
10. Gullo L, Ventrucci M, Barakat B, Migliori M, Tomassetti P, Pezzilli R. Effect of secretin on serum pancreatic enymes and on the Wirsung duct in chronic nonpathological pancreatic hyperenzymemia. Pancreatology 2003; 3: 191-194.
11. Gullo L, Mantovani V, Manca M, Migliori M, Bastagli L, Pezzilli R. Mutations of the CFTR gene in idiopathic pancreatic hyperenzymemia.Pancreas 2005; 31: 350-352.
12. Gullo L, Manca M, Migliori M, Calculli L,Bastagli L, Salizzoni E. Pancreatic hyperenzymemia
and dyslipidemia: a study of the pancreas by magnetic resonance and evaluation of the diurnal variations of serum pancreatic enzymes. (In publication).
13. Cavallini G, Frulloni L, Vaona B, Di Francesco V, Bovo P. Is hyperamylasemia related to dyslipidemia?Gastroenterology 1997; 112: 1058 (Letter to the Editor).
14. Martinez J, Gomez A, Palazon JM, Gutierrez A, Perez-Mateo M. Asymptomatic chronic hyperamilasemia of unknown origin: an infrequent entity? Gastroenterology 1997;112: 1057 (Letter to the Editor).
15. Ventrucci M, Pezzilli R, Festi D. Clinical significance of chronic hyperamylasemia.Dig Dis Sci 1991; 36: 1517-1522.
16. Gilbert A, Leerboullet P. La cholémie simple familiale. Sem Med Paris 1901; 21: 241-243.
17. Rowland LP, Willner J, Cerri C, Di Mauro S, Miranda A. Approaches to the membrane
theory of Duchenne muscular dystrophy. In: Angelini C, Danieli GA, Fontanari D (eds). Muscular dystrophy research: advances end new trends. Excerpta Medica, Amsterdam. 1980, pp 3-13.
18. Uncini A, Papasso M, Di Muzio A. IperCKemia asintomatica: ruolo dell'indagine neurofisiologica. Neurol Sci 2001; 22: S581-S583.
19. Prelle A, et al. Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levels. J Neurol 2002; 249: 305-311.
20. Gullo L, Migliori M, Tomassetti P, Steinberg W. Pancreatic hyperenzymaemia and hypertransaminasaemia in healthy subjects. Report of three cases. Dig Liv Dis 2003; 35: 58-60.